• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HSO
Click for more information
0.00% $2.43

HEALTHSCOPE LIMITED. - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
HSO FIRB Approval received for Brookfield transactionPRICE SENSITIVE19/03/19
HSO FY19 Half Year Results PresentationPRICE SENSITIVE14/02/19
HSO FY19 Half Year Results ReleasePRICE SENSITIVE14/02/19
HSO Half Yearly Report and AccountsPRICE SENSITIVE14/02/19
HSO Dividend/Distribution - HSOPRICE SENSITIVE14/02/19
HSO Change in substantial holding confirmation statementPRICE SENSITIVE01/02/19
HSO Update on BGH-Australiansuper consortium proposalPRICE SENSITIVE01/02/19
HSO Healthscope enters into Implementation Deed with BrookfieldPRICE SENSITIVE01/02/19
HSO Update on 1HFY19 Trading PerformancePRICE SENSITIVE01/02/19
HSO Update on Brookfield ProposalPRICE SENSITIVE21/01/19
HSO Update on BGH- AustralianSuper Consortium ProposalPRICE SENSITIVE21/12/18
HSO Update on Brookfield ProposalPRICE SENSITIVE21/12/18
HSO Pause in TradingPRICE SENSITIVE21/12/18
HSO Update on Brookfield Proposal - exclusivity periodPRICE SENSITIVE19/11/18
HSO Healthscope announces proposal from BrookfieldPRICE SENSITIVE12/11/18
HSO BGH Consortium - cash settled equity swap and Form 604PRICE SENSITIVE09/11/18
HSO MD & CEO's Address to ShareholdersPRICE SENSITIVE31/10/18
HSO Chairman's AGM Address to ShareholdersPRICE SENSITIVE31/10/18
HSO Update on 1QFY19 tradingPRICE SENSITIVE31/10/18
HSO BGH Consortium increases interest in HealthscopePRICE SENSITIVE31/10/18
HSO BGH Consortium cash settled equity swapPRICE SENSITIVE30/10/18
HSO Update on unsolicited and conditional acquisition proposalPRICE SENSITIVE30/10/18
HSO BGH Consortium cash settled equity swap and Form 604PRICE SENSITIVE25/10/18
HSO Unsolicited and Conditional Acquisition ProposalPRICE SENSITIVE23/10/18
HSO FY18 results presentationPRICE SENSITIVE21/08/18
HSO Appendix 4E, FY18 media release and Annual ReportPRICE SENSITIVE21/08/18
HSO Outcome of Strategic Review of Hospital Property AssetsPRICE SENSITIVE21/08/18
HSO Healthscope announces sale of Asian Pathology to TPGPRICE SENSITIVE30/07/18
HSO Update on acquisition proposals & property strategic reviewPRICE SENSITIVE22/05/18
HSO Outcomes of portfolio review and updated earnings guidancePRICE SENSITIVE22/05/18
HSO Unsolicited, non-binding indicative proposal from BrookfleldPRICE SENSITIVE14/05/18
HSO Unsolicited and conditional acquisition proposalPRICE SENSITIVE26/04/18
HSO FY18 Half Year Results ReleasePRICE SENSITIVE15/02/18
HSO Half Yearly Report and AccountsPRICE SENSITIVE15/02/18
HSO Dividend/Distribution - HSOPRICE SENSITIVE15/02/18
HSO MD & CEO's Address to ShareholdersPRICE SENSITIVE19/10/17
HSO FY17 Financial Report Media ReleasePRICE SENSITIVE23/08/17
HSO Appendix 4EPRICE SENSITIVE23/08/17
HSO Healthscope announces sale of its medical centresPRICE SENSITIVE18/08/17
HSO Healthscope announces appointment of new MD and CEOPRICE SENSITIVE03/04/17
HSO Appendix 4D FY17 Half Yearly Report and AccountsPRICE SENSITIVE22/02/17
HSO Market Update-HSO.AX PRICE SENSITIVE21/10/16
HSO Appendix 4E and FY16 Consolidated Financial Report-HSO.AX PRICE SENSITIVE23/08/16
HSO Award of Northern Beaches Hospital contract,HSO-PRY.AX PRICE SENSITIVE14/07/16
HSO Healthscope issues US$300m in US Private Placement NotesPRICE SENSITIVE23/03/16
HSO Appendix 4D FY16 Half Yearly Report and AccountsPRICE SENSITIVE23/02/16
HSO Dividend/Distribution - HSOPRICE SENSITIVE23/02/16
HSO Sale of shareholding by CT Healthscope Holdings L.P.PRICE SENSITIVE24/11/15
HSO Healthscope to issue $8.2 million in Ordinary SharesPRICE SENSITIVE19/11/15
HSO Reduction in shareholding by CT Healthscope Holdings L.P.PRICE SENSITIVE10/09/15
HSO Appendix 4E and FY15 Consolidated Financial ReportPRICE SENSITIVE25/08/15
HSO Sale of Australian Pathology operations for A$105 millionPRICE SENSITIVE23/06/15
HSO Half Yearly Report and AccountsPRICE SENSITIVE24/02/15
LEI +Leighton signs Northern Beaches Hospital contractPRICE SENSITIVE11/12/14
HSO Northern Beaches Hospital - Contractual close announcedPRICE SENSITIVE11/12/14
LEI +Leighton part of Northern Beaches Hospital deliveryPRICE SENSITIVE30/10/14
HSO Northern Beaches Hospital - Healthscope preferred bidderPRICE SENSITIVE29/10/14
WTF +ZSP: Wotif.com Hdgs to be removed from the S&P/ASX IndicesPRICE SENSITIVE08/10/14
HSO Admission to Official ListPRICE SENSITIVE28/07/14
HSO FIRB Approval received for Brookfield transaction
19/03/19PRICE SENSITIVE
HSO FY19 Half Year Results Presentation
14/02/19PRICE SENSITIVE
HSO FY19 Half Year Results Release
14/02/19PRICE SENSITIVE
HSO Half Yearly Report and Accounts
14/02/19PRICE SENSITIVE
HSO Dividend/Distribution - HSO
14/02/19PRICE SENSITIVE
HSO Change in substantial holding confirmation statement
01/02/19PRICE SENSITIVE
HSO Update on BGH-Australiansuper consortium proposal
01/02/19PRICE SENSITIVE
HSO Healthscope enters into Implementation Deed with Brookfield
01/02/19PRICE SENSITIVE
HSO Update on 1HFY19 Trading Performance
01/02/19PRICE SENSITIVE
HSO Update on Brookfield Proposal
21/01/19PRICE SENSITIVE
HSO Update on BGH- AustralianSuper Consortium Proposal
21/12/18PRICE SENSITIVE
HSO Update on Brookfield Proposal
21/12/18PRICE SENSITIVE
HSO Pause in Trading
21/12/18PRICE SENSITIVE
HSO Update on Brookfield Proposal - exclusivity period
19/11/18PRICE SENSITIVE
HSO Healthscope announces proposal from Brookfield
12/11/18PRICE SENSITIVE
HSO BGH Consortium - cash settled equity swap and Form 604
09/11/18PRICE SENSITIVE
HSO MD & CEO's Address to Shareholders
31/10/18PRICE SENSITIVE
HSO Chairman's AGM Address to Shareholders
31/10/18PRICE SENSITIVE
HSO Update on 1QFY19 trading
31/10/18PRICE SENSITIVE
HSO BGH Consortium increases interest in Healthscope
31/10/18PRICE SENSITIVE
HSO BGH Consortium cash settled equity swap
30/10/18PRICE SENSITIVE
HSO Update on unsolicited and conditional acquisition proposal
30/10/18PRICE SENSITIVE
HSO BGH Consortium cash settled equity swap and Form 604
25/10/18PRICE SENSITIVE
HSO Unsolicited and Conditional Acquisition Proposal
23/10/18PRICE SENSITIVE
HSO FY18 results presentation
21/08/18PRICE SENSITIVE
HSO Appendix 4E, FY18 media release and Annual Report
21/08/18PRICE SENSITIVE
HSO Outcome of Strategic Review of Hospital Property Assets
21/08/18PRICE SENSITIVE
HSO Healthscope announces sale of Asian Pathology to TPG
30/07/18PRICE SENSITIVE
HSO Update on acquisition proposals & property strategic review
22/05/18PRICE SENSITIVE
HSO Outcomes of portfolio review and updated earnings guidance
22/05/18PRICE SENSITIVE
HSO Unsolicited, non-binding indicative proposal from Brookfleld
14/05/18PRICE SENSITIVE
HSO Unsolicited and conditional acquisition proposal
26/04/18PRICE SENSITIVE
HSO FY18 Half Year Results Release
15/02/18PRICE SENSITIVE
HSO Half Yearly Report and Accounts
15/02/18PRICE SENSITIVE
HSO Dividend/Distribution - HSO
15/02/18PRICE SENSITIVE
HSO MD & CEO's Address to Shareholders
19/10/17PRICE SENSITIVE
HSO FY17 Financial Report Media Release
23/08/17PRICE SENSITIVE
HSO Appendix 4E
23/08/17PRICE SENSITIVE
HSO Healthscope announces sale of its medical centres
18/08/17PRICE SENSITIVE
HSO Healthscope announces appointment of new MD and CEO
03/04/17PRICE SENSITIVE
HSO Appendix 4D FY17 Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE
HSO Market Update-HSO.AX
21/10/16PRICE SENSITIVE
HSO Appendix 4E and FY16 Consolidated Financial Report-HSO.AX
23/08/16PRICE SENSITIVE
HSO Award of Northern Beaches Hospital contract,HSO-PRY.AX
14/07/16PRICE SENSITIVE
HSO Healthscope issues US$300m in US Private Placement Notes
23/03/16PRICE SENSITIVE
HSO Appendix 4D FY16 Half Yearly Report and Accounts
23/02/16PRICE SENSITIVE
HSO Dividend/Distribution - HSO
23/02/16PRICE SENSITIVE
HSO Sale of shareholding by CT Healthscope Holdings L.P.
24/11/15PRICE SENSITIVE
HSO Healthscope to issue $8.2 million in Ordinary Shares
19/11/15PRICE SENSITIVE
HSO Reduction in shareholding by CT Healthscope Holdings L.P.
10/09/15PRICE SENSITIVE
HSO Appendix 4E and FY15 Consolidated Financial Report
25/08/15PRICE SENSITIVE
HSO Sale of Australian Pathology operations for A$105 million
23/06/15PRICE SENSITIVE
HSO Half Yearly Report and Accounts
24/02/15PRICE SENSITIVE
LEI +Leighton signs Northern Beaches Hospital contract
11/12/14PRICE SENSITIVE
HSO Northern Beaches Hospital - Contractual close announced
11/12/14PRICE SENSITIVE
LEI +Leighton part of Northern Beaches Hospital delivery
30/10/14PRICE SENSITIVE
HSO Northern Beaches Hospital - Healthscope preferred bidder
29/10/14PRICE SENSITIVE
WTF +ZSP: Wotif.com Hdgs to be removed from the S&P/ASX Indices
08/10/14PRICE SENSITIVE
HSO Admission to Official List
28/07/14PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.